What's new

Human medicines European public assessment report (EPAR): Izelvay, avacincaptad pegol, Status: Application withdrawn

Human medicines European public assessment report (EPAR): Izelvay, avacincaptad pegol, Status: Application withdrawn

Feb 9, 2025 - 22:26
 0
Human medicines European public assessment report (EPAR): Izelvay, avacincaptad pegol, Status: Application withdrawn
Human medicines European public assessment report (EPAR): Izelvay, avacincaptad pegol, Status: Application withdrawn
Read More

Tags:

Previous Article

Non-clinical Working Party

Next Article

Exclusive: Here’s who Hegseth may task to put together Trump’s Iron Dome plan

Related Posts

Human medicines European public assessment report (EPAR): Giotrif, afatinib, Date of authorisation: 25/09/2013, Revision: 16, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 26, 2025  0

Human medicines European public assessment report (EPAR): Keytruda, pembrolizumab, Date of authorisation: 17/07/2015, Revision: 63, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025  0

Human medicines European public assessment report (EPAR): Locametz, gozetotide, Date of authorisation: 09/12/2022, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 13, 2025  0